ENTREPRENEUR.
INNOVATOR.
MENTOR.

Jeff Aronin has decades of experience developing innovative global biotech and health care companies. His keen ability to identify ideas and scientific innovations with the highest potential to change lives and improve the world has made Jeff one of the most impactful and successful leaders in the life science sector.

As an entrepreneur and scientific visionary, with a focus on addressing unmet patient and societal needs, Jeff has received U.S. Food and Drug Administration (FDA) approval of nearly a dozen new medicines and technologies. His companies are renowned for advancing science, with a record number of breakthroughs helping patients.

In addition to putting his experience and passion to work building bioscience firms, Jeff serves as a mentor to many, sharing his expertise with up-and-coming entrepreneurs.

ABOUT

Challenges which others have deemed unsolvable are the problems we are solving.

— Jeff Aronin

BUILDING COMPANIES THAT IMPROVE LIVES

Jeff is the chairman and chief executive officer of Paragon Biosciences, LLC, a life science innovator that creates, invests in and builds life science companies in artificial intelligence, cell and gene therapy, synthetic biology and biopharmaceuticals. Paragon founded Castle Creek Biosciences, CiRC Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, and Skyline Biosciences, and maintains a consistent flow of incubating companies supported by the replicable Paragon Innovation Capital™ model.

Since 2017, Paragon and its partners have invested approximately $1 billion to build life science companies and expects ongoing investments of up to $500 million per year.

BUILDING COMPANIES THAT IMPROVE LIVES

Jeff is the chairman and chief executive officer of Paragon Biosciences, LLC, a life science innovator that creates, invests in and builds life science companies in artificial intelligence, cell and gene therapy, synthetic biology and biopharmaceuticals. Paragon founded Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, and Skyline Biosciences. The company maintains a consistent flow of incubating companies created and supported by the replicable Paragon Innovation Capital™ model.

Since 2017, Paragon and its partners have invested or committed to invest more than $1 billion in its portfolio companies and expects ongoing investments of up to $500 million annually to address unmet need through life science breakthroughs.

HONORS

Throughout his career, Jeff has received honors for his entrepreneurship and patient-focused dedication to bringing new medicines to market. Examples include:

PHILANTHROPY

As founder and co-chairman of MATTER – a health-technology startup incubator – Jeff has led one of Chicago’s most remarkable, philanthropic venture-innovation successes, with more than 200 healthcare companies at any one time, more than 60 corporate sponsors, and more than $1 billion in deals since 2015.

Jeff Aronin Philanthropy

MEMBERSHIP AND BOARDS

He is a member of The Commercial Club of Chicago and serves on several corporate and civic boards including Discover Financial Services and The Aspen Institute.

GLOBAL AND LOCAL

Jeff Aronin is a believer in education as a change agent, Jeff contributes to organizations which provide a catalyst for entrepreneurs; encourage youth wellness, sports and achievement; improve community parks; promote tolerance and understanding through faith-based organizations; and preserve our history and its lessons.

Jeff serves as a mentor to students and young professionals and is a frequent lecturer at the University of Chicago’s Booth School of Business and Northwestern University’s Kellogg School of Business.

Jeffrey Aronin Philanthropy

CONTACT

To contact Jeff, please fill out the form below. For business and media inquiries, please use this form.

jeffreyaronin